Category: news

We have been selected as a finalist for Hello Tomorrow Japan Challenge 2024. See more

We will be exhibiting at the GHIT Fund R&D Forum. See more

Rised from Eiken chemical.See more

We have been selected for MedTech Innovator Asia Pacific 2024 Accelerator Cohort Program. See more

Started a collaborative research with the Influenza Virus Research Center at the National Institute of Infectious Diseases

Nanotis, University of Tokyo startup, is raising funds in the series A funding round to accelerate the development of next-generation infection testing devices Nanotis Corporation (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita) , a University of Tokyo-affiliated startup engaged in the research and development of next-generation infection testing devices, […]

Press Release Nanotis Corporation (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita) (hereinafter “Nanotis”), a University of Tokyo-affiliated venture engaged in the research and development of next-generation infection testing devices, has received funding from Hamamatsu Photonics K.K. (Head Office: Hamamatsu, Shizuoka; President and CEO: Akira Hiruma) (hereinafter “Hamamatsu Photonics”) and […]

Press Release Nanotis (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita), a University of Tokyo-affiliated startup that is developing rapid diagnostic devices for infectious diseases such as influenza, has received funding from Taisho Pharmaceutical Co., Ltd. (Head Office: Toshima, Tokyo; CEO: Shigeru Uehara) in its pre-series A funding round.   […]

Press Release Nanotis (Head Office: Shibuya, Tokyo; CEO, Founder: Lisa Sakashita), the University of Tokyo-related start-up that is developing rapid diagnostic devices for infectious diseases, has raised ¥45,000,000 JPY (~$400,000 USD) from Shizuoka Capital (Head Office: Shizuoka, Shizuoka; President: Rinzo Mizutani), Hamamatsu Photonics (Head Office: Hamamatsu, Shizuoka; President: Akira Hiruma), […]